Sandoz settles pricing suits with Florida, California

Novartis' ($NVS) generics unit Sandoz has agreed to pay $150 million to settle pricing-fraud lawsuits filed by the states of Florida and California. It's the latest settlement in ongoing probes of average wholesale pricing in the pharma industry. Report